C E Steuer - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C E Steuer

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018

Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patientsJ Remon, C E Steuer, S S Ramalingam, et al.

Clinical Pharmacology and Therapeutics|February 14, 2015

Innovative Clinical Trials: The LUNG-MAP StudyC E Steuer, V Papadimitrakopoulou, R S Herbst, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024

Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLCH A Yu, C Baik, D-W Kim, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018

Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patientsJ Remon, C E Steuer, S S Ramalingam, et al.

Clinical Pharmacology and Therapeutics|February 14, 2015

Innovative Clinical Trials: The LUNG-MAP StudyC E Steuer, V Papadimitrakopoulou, R S Herbst, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024

Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLCH A Yu, C Baik, D-W Kim, et al.

Pageof 1